Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


14.08.2017

1 Am J Surg
6 Anticancer Res
1 BMC Cancer
1 Br J Cancer
3 Cancer
1 Cancer Lett
1 Curr Treat Options Oncol
3 Dis Colon Rectum
5 Eur J Cancer
3 Gastroenterology
1 Gut
1 Hum Pathol
1 Int J Cancer
8 Int J Colorectal Dis
2 Int J Oncol
1 J Clin Oncol
1 J Pathol
4 J Surg Oncol
2 Lancet Oncol
1 Oncogene
1 Oncol Rep
9 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. TSAI C, Hague C, Xiong W, Raval M, et al
    Evaluation of endorectal ultrasound (ERUS) and MRI for prediction of circumferential resection margin (CRM) for rectal cancer.
    Am J Surg. 2017;213:936-942.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. BACALBASA N, Stoica C, Balescu I
    Multiple Visceral Resections for Synchronous Left and Transverse Colon Adenocarcinoma with Gastrocolic-cutaneous Fistula - Case Report and Literature Review.
    Anticancer Res. 2017;37:2601-2607.
    PubMed     Text format     Abstract available

  3. RUBIO CA
    Are Corrupted Non-dysplastic Colonic Crypts the First Histological Event in Experimental Colonic Carcinogenesis?
    Anticancer Res. 2017;37:2265-2268.
    PubMed     Text format     Abstract available

  4. NUMATA M, Yamaguchi T, Kinugasa Y, Shiomi A, et al
    Index of Estimated Benefit from Lateral Lymph Node Dissection for Middle and Lower Rectal Cancer.
    Anticancer Res. 2017;37:2549-2555.
    PubMed     Text format     Abstract available

  5. BACALBASA N, Balescu I
    Infracolic Approach to the Superior Mesenteric Vessels for a Large Pancreatic Tumor with Right Colon Invasion - A Case Report and Literature Review.
    Anticancer Res. 2017;37:2609-2613.
    PubMed     Text format     Abstract available

  6. EISTERER W, Piringer G, DE Vries A, Ofner D, et al
    Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
    Anticancer Res. 2017;37:2683-2691.
    PubMed     Text format     Abstract available

  7. BARABINO M, Gatti A, Santambrogio R, Polizzi M, et al
    Intraoperative Local Ablative Therapies Combined with Surgery for the Treatment of Bilobar Colorectal Liver Metastases.
    Anticancer Res. 2017;37:2743-2750.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. GUIRIGUET C, Pera G, Castells A, Toran P, et al
    Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    BMC Cancer. 2017;17:524.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. TORRING ML, Murchie P, Hamilton W, Vedsted P, et al
    Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  10. SUN Z, Ke X, Salzberg SL, Kim D, et al
    The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.
    Cancer. 2017;123:1507-1515.
    PubMed     Text format     Abstract available

  11. COOPER GS, Kou TD, Dor A, Koroukian SM, et al
    Cancer preventive services, socioeconomic status, and the Affordable Care Act.
    Cancer. 2017;123:1585-1589.
    PubMed     Text format     Abstract available

  12. LUDMIR EB, Palta M, Willett CG, Czito BG, et al
    Total neoadjuvant therapy for rectal cancer: An emerging option.
    Cancer. 2017;123:1497-1506.
    PubMed     Text format     Abstract available


    Cancer Lett

  13. EDER S, Arndt A, Lamkowski A, Daskalaki W, et al
    Baseline MAPK signaling activity confers intrinsic radioresistance to KRAS-mutant colorectal carcinoma cells by rapid upregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K).
    Cancer Lett. 2017;385:160-167.
    PubMed     Text format     Abstract available


    Curr Treat Options Oncol

  14. RANA N, Chakravarthy AB, Kachnic LA
    Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design.
    Curr Treat Options Oncol. 2017;18:13.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  15. KANG SI, Kim DW, Cho JY, Park J, et al
    Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer?
    Dis Colon Rectum. 2017;60:936-944.
    PubMed     Text format     Abstract available

  16. RATNAPRADIPA KL, Lian M, Jeffe DB, Davidson NO, et al
    Patient, Hospital, and Geographic Disparities in Laparoscopic Surgery Use Among Surveillance, Epidemiology, and End Results-Medicare Patients With Colon Cancer.
    Dis Colon Rectum. 2017;60:905-913.
    PubMed     Text format     Abstract available

  17. TAN WJ, Dorajoo SR, Chee MYM, Tan WS, et al
    A Novel Derivation Predicting Survival After Primary Tumor Resection in Stage IV Colorectal Cancer: Validation of a Prognostic Scoring Model and an Online Calculator to Provide Individualized Survival Estimation.
    Dis Colon Rectum. 2017;60:895-904.
    PubMed     Text format     Abstract available


    Eur J Cancer

  18. FRIN AC, Evesque L, Gal J, Benezery K, et al
    Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Eur J Cancer. 2017;72:124-136.
    PubMed     Text format     Abstract available

  19. SCHAFFAR R, Rachet B, Belot A, Woods LM, et al
    Estimation of net survival for cancer patients: Relative survival setting more robust to some assumption violations than cause-specific setting, a sensitivity analysis on empirical data.
    Eur J Cancer. 2017;72:78-83.
    PubMed     Text format     Abstract available

  20. MECHERA R, Schuster T, Rosenberg R, Speich B, et al
    Lymph node yield after rectal resection in patients treated with neoadjuvant radiation for rectal cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2017;72:84-94.
    PubMed     Text format     Abstract available

  21. ROVERS KP, Simkens GA, Vissers PA, Lemmens VE, et al
    Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.
    Eur J Cancer. 2017;75:132-140.
    PubMed     Text format     Abstract available

  22. STINTZING S, Tejpar S, Gibbs P, Thiebach L, et al
    Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomes.
    Eur J Cancer. 2017;84:69-80.
    PubMed     Text format     Abstract available


    Gastroenterology

  23. HE C, Yu T, Shi Y, Ma C, et al
    MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    Gastroenterology. 2017;152:1434-1448.
    PubMed     Text format     Abstract available

  24. TSOI H, Chu ESH, Zhang X, Sheng J, et al
    Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.
    Gastroenterology. 2017;152:1419-1433.
    PubMed     Text format     Abstract available

  25. LEONG RW, Ooi M, Corte C, Yau Y, et al
    Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
    Gastroenterology. 2017;152:1337-1344.
    PubMed     Text format     Abstract available


    Gut

  26. KHAN K, Rata M, Cunningham D, Koh DM, et al
    Functional imaging and circulating biomarkers of response to regorafenib in treatment-refractory metastatic colorectal cancer patients in a prospective phase II study.
    Gut. 2017 Aug 8. pii: gutjnl-2017-314178. doi: 10.1136/gutjnl-2017-314178.
    PubMed     Text format     Abstract available


    Hum Pathol

  27. WANG L, Liu Z, Fisher KW, Ren F, et al
    Prognostic value of programmed death ligand 1, p53, and Ki-67 in patients with advanced stage colorectal cancer.
    Hum Pathol. 2017 Aug 4. pii: S0046-8177(17)30266.
    PubMed     Text format     Abstract available


    Int J Cancer

  28. JUBRAN R, Kocsis J, Garam N, Malati E, et al
    Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30918.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  29. KIM HJ, Song JH, Ahn HS, Choi BH, et al
    Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
    Int J Colorectal Dis. 2017;32:723-727.
    PubMed     Text format     Abstract available

  30. CONNOLLY JG, Goldstone SE
    Squamous cell dysplasia in the proximal rectum of three patients treated for ulcerative colitis on immunomodulators.
    Int J Colorectal Dis. 2017;32:753-756.
    PubMed     Text format     Abstract available

  31. TSUKAMOTO S, Kanemitsu Y, Shida D, Ochiai H, et al
    Comparison of the clinical results of abdominoperanal intersphincteric resection and abdominoperineal resection for lower rectal cancer.
    Int J Colorectal Dis. 2017;32:683-689.
    PubMed     Text format     Abstract available

  32. HUGHES DL, Cornish J, Morris C
    Functional outcome following rectal surgery-predisposing factors for low anterior resection syndrome.
    Int J Colorectal Dis. 2017;32:691-697.
    PubMed     Text format     Abstract available

  33. YANG SY, Han J, Han YD, Cho MS, et al
    Intraoperative colonoscopy for the assessment and prevention of anastomotic leakage in low anterior resection for rectal cancer.
    Int J Colorectal Dis. 2017;32:709-714.
    PubMed     Text format     Abstract available

  34. LIGHTNER AL, Moncrief SB, Smyrk TC, Pemberton JH, et al
    Long-standing Crohn's disease and its implication on anal squamous cell cancer management.
    Int J Colorectal Dis. 2017;32:661-666.
    PubMed     Text format     Abstract available

  35. LOWES M, Kleiss M, Lueck R, Detken S, et al
    The utilization of multidisciplinary tumor boards (MDT) in clinical routine: results of a health care research study focusing on patients with metastasized colorectal cancer.
    Int J Colorectal Dis. 2017 Aug 5. doi: 10.1007/s00384-017-2871.
    PubMed     Text format     Abstract available

  36. CRISPIN A, Klinger C, Rieger A, Strahwald B, et al
    The DGAV risk calculator: development and validation of statistical models for a web-based instrument predicting complications of colorectal cancer surgery.
    Int J Colorectal Dis. 2017 Aug 10. doi: 10.1007/s00384-017-2869.
    PubMed     Text format     Abstract available


    Int J Oncol

  37. KANG KA, Piao MJ, Ryu YS, Hyun YJ, et al
    Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4091.
    PubMed     Text format     Abstract available

  38. XU H, Zeng Y, Liu L, Gao Q, et al
    PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism.
    Int J Oncol. 2017 Aug 2. doi: 10.3892/ijo.2017.4090.
    PubMed     Text format     Abstract available


    J Clin Oncol

  39. SUD A, Thomsen H, Sundquist K, Houlston RS, et al
    Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    J Clin Oncol. 2017 Mar 13:JCO2016709709. doi: 10.1200/JCO.2016.70.9709.
    PubMed     Text format     Abstract available


    J Pathol

  40. BARROW TM, Klett H, Toth R, Bohm J, et al
    Smoking is associated with hypermethylation of the APC 1A promoter in colorectal cancer: the ColoCare Study.
    J Pathol. 2017 Aug 9. doi: 10.1002/path.4955.
    PubMed     Text format     Abstract available


    J Surg Oncol

  41. SUN Y, Lin H, Lu X, Huang Y, et al
    A nomogram to predict distant metastasis after neoadjuvant chemoradiotherapy and radical surgery in patients with locally advanced rectal cancer.
    J Surg Oncol. 2017;115:462-469.
    PubMed     Text format     Abstract available

  42. IMAI K, Castro Benitez C, Allard MA, Vibert E, et al
    Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease.
    J Surg Oncol. 2017;115:488-496.
    PubMed     Text format     Abstract available

  43. SAXENA A, Valle SJ, Liauw W, Morris DL, et al
    Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    J Surg Oncol. 2017;115:417-424.
    PubMed     Text format     Abstract available

  44. CONNELL LC, Boucher TM, Chou JF, Capanu M, et al
    Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    J Surg Oncol. 2017;115:480-487.
    PubMed     Text format     Abstract available


    Lancet Oncol

  45. WASAN HS, Gibbs P, Sharma NK, Taieb J, et al
    First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trial
    Lancet Oncol. 2017 Aug 3. pii: S1470-2045(17)30457.
    PubMed     Text format     Abstract available

  46. SCHMOLL HJ
    Selective internal radiotherapy in advanced colorectal cancer: only for right-sided tumours?
    Lancet Oncol. 2017 Aug 3. pii: S1470-2045(17)30589.
    PubMed     Text format    


    Oncogene

  47. AHMAD R, Kumar B, Chen Z, Chen X, et al
    Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/beta-catenin signaling.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  48. WANG M, He SF, Liu LL, Sun XX, et al
    Potential role of ZEB1 as a DNA repair regulator in colorectal cancer cells revealed by cancer-associated promoter profiling.
    Oncol Rep. 2017 Aug 8. doi: 10.3892/or.2017.5888.
    PubMed     Text format     Abstract available


    PLoS One

  49. ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
    Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
    PLoS One. 2017;12:e0169875.
    PubMed     Text format     Abstract available

  50. HENLEY AB, Yang L, Chuang KL, Sahuri-Arisoylu M, et al
    Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'.
    PLoS One. 2017;12:e0170917.
    PubMed     Text format     Abstract available

  51. GLADILIN E
    Graph-theoretical model of global human interactome reveals enhanced long-range communicability in cancer networks.
    PLoS One. 2017;12:e0170953.
    PubMed     Text format     Abstract available

  52. GLISZCZYNSKA A, Niezgoda N, Gladkowski W, Switalska M, et al
    Isoprenoid-phospholipid conjugates as potential therapeutic agents: Synthesis, characterization and antiproliferative studies.
    PLoS One. 2017;12:e0172238.
    PubMed     Text format     Abstract available

  53. LI Q, Wang Y, Lai Y, Xu P, et al
    HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling.
    PLoS One. 2017;12:e0182588.
    PubMed     Text format     Abstract available

  54. KUTUK O, Aytan N, Karakas B, Kurt AG, et al
    Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells.
    PLoS One. 2017;12:e0182809.
    PubMed     Text format     Abstract available

  55. CHOI YR, Kim JH, Park SJ, Hur BY, et al
    Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images.
    PLoS One. 2017;12:e0182596.
    PubMed     Text format     Abstract available

  56. SIESING C, Sorbye H, Dragomir A, Pfeiffer P, et al
    High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer.
    PLoS One. 2017;12:e0182512.
    PubMed     Text format     Abstract available

  57. YOUNS M, Abdel Halim Hegazy W
    The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.
    PLoS One. 2017;12:e0169335.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: